Medicenna Therapeutics Corp
Medicenna Therapeutics Corp, based in Toronto, ON, is a clinical-stage immunotherapy company focused on harnessing directed evolution to create engineered interleukins, referred to as Superkines. These innovative therapies are designed to fine-tune, modulate, or amplify the immune system, aiming to address complex diseases and provide hope for patients with unmet medical needs.
The company's pipeline emphasizes the development of interleukin-2, interleukin-4, and interleukin-13 super-agonists and antagonists, enhancing their specificity, functionality, and safety compared to unmodified interleukins. By enabling customizable, multi-functional treatments, Medicenna aims to deliver targeted therapies directly to areas where they are most needed.
Generated from the website
Also at this address
You might also like
Partial Data by Infogroup (c) 2024. All rights reserved.
